Charlie's Holdings backs Trump plan to streamline FDA flavored vape approvals
Bitget2026/09/24 13:03- Charlie’s Holdings issued a statement backing the Trump administration’s plan to revisit FDA rules for the Premarket Tobacco Application (PMTA) process.
- The company expects this shift to speed authorizations for flavored vapes.
- Charlie’s said it has sought FDA marketing authorization since September 2020 for some tobacco-derived nicotine e-liquids.
- It has made additional filings since May 2022 for synthetic nicotine products.
- Management said it retains 678 timely filed PMTA assets following the sale of 16 PACHA brand PMTA products in 2025 to a large tobacco company.
- The company said a streamlined pathway for timely filed PMTAs could raise the value of its remaining PACHA portfolio.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Lithium-For-Earth Raises KRW 1.32 Billion in Private Placement
Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion
Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.
Subaru Publishes Transcript of First-Half FYE 2027 Financial Results Presentation
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.